Opportunity Information: Apply for W81XWH 11 TSCRP IDA

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Tuberous Sclerosis Complex Idea Development Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on Apr 28, 2011 and posted on Apr 28, 2011.
  • Applicants must submit their applications by Aug 1, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $2,700,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 3 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 11 TSCRP IDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The DOD Tuberous Sclerosis Complex (TSC) Idea Development Award is a Department of Defense funding opportunity offered through the Tuberous Sclerosis Complex Research Program (TSCRP), which was created in 2002 to support research that reduces the clinical burden of TSC. The program is centered on improving understanding of TSC disease mechanisms (pathogenesis) and translating those insights into better approaches to care for people living with TSC. For the FY11 cycle, this award is positioned as a driver for bold, field-shaping research rather than routine or incremental work.

The core purpose of the Idea Development Award is to fund high-impact, innovative projects that can move TSC research forward in a meaningful way. The announcement emphasizes that proposed studies should be original and capable of changing the concepts, methods, or overall direction of TSC research. Innovation is defined broadly: it can come from introducing a new scientific paradigm, challenging widely held assumptions, reframing a long-standing problem from a different angle, or applying uniquely creative approaches. Innovation can also be reflected in the study concept, the research tools or technologies used, the design of clinical interventions (as concepts, not as formal trials), or the adaptation of existing methods and technologies to TSC in a genuinely new way. In contrast, projects that primarily extend previously published findings in a stepwise or incremental manner are explicitly discouraged and may be considered non-responsive to the intent of the mechanism.

In terms of the types of work supported, preclinical research is encouraged, which signals openness to laboratory studies, animal models, mechanistic experiments, biomarker development, and other translationally oriented efforts that are not human clinical trials. At the same time, clinical trials are not permitted under this award, so applicants need to shape any human-related research accordingly (for example, focusing on observational, mechanistic, or preparatory work rather than interventional trials). Another key expectation is that applicants include preliminary data that directly supports the feasibility and rationale of the proposed project, indicating that while the program seeks creative ideas, it also expects evidence that the idea can be executed and is grounded in credible early findings.

Collaboration is highlighted as a major priority for this funding opportunity. The FY11 TSCRP particularly encourages partnerships between basic scientists and clinical researchers to strengthen translation from mechanism to patient relevance. It also welcomes collaborations between academic investigators and biotechnology or pharmaceutical industry scientists, reflecting an interest in accelerating the pathway from discovery to practical application. The program further notes that collaborations bringing in new disciplines or attracting new investigators into the TSC research space are strongly encouraged, suggesting that cross-pollination from adjacent fields and fresh perspectives are viewed as a way to catalyze breakthroughs.

Administratively, this opportunity was issued by the Department of the Army (USAMRAA) under Funding Opportunity Number W81XWH-11-TSCRP-IDA. The funding instrument type is listed as a cooperative agreement and grant, and it falls under the Science and Technology and other Research and Development category (CFDA 12.420, Military Medical Research and Development). The program anticipated making about three awards, with an estimated total funding level of $2.7 million. Cost sharing or matching is not required. Eligibility is described as unrestricted, meaning a wide range of entity types can apply, subject to any additional eligibility clarifications contained in the full announcement. Key dates for the archived FY11 cycle include a posting date of April 28, 2011, an original and final closing date of August 1, 2011, and an archive date of August 31, 2011. For technical assistance with accessing the full announcement or submission systems, the notice points applicants to the CDMRP help resources (PA HELP and eReceipt HELP) via phone at 301-682-5507 or email at help@cdmrp.org.

FAQs: DOD Tuberous Sclerosis Complex (TSC) Idea Development Award (FY11)

What is the DOD Tuberous Sclerosis Complex (TSC) Idea Development Award?

The TSC Idea Development Award is a Department of Defense funding opportunity offered through the Tuberous Sclerosis Complex Research Program (TSCRP). It is intended to support research that reduces the clinical burden of tuberous sclerosis complex (TSC) by improving understanding of disease mechanisms and translating those insights into better approaches to care.

What is the goal of the TSCRP program overall?

The TSCRP was created in 2002 to support research aimed at reducing the clinical burden of TSC. The program focuses on understanding TSC pathogenesis (disease mechanisms) and translating discoveries into improved care for people living with TSC.

What is the main purpose of the Idea Development Award mechanism?

The core purpose is to fund high-impact, innovative projects that can move TSC research forward in a meaningful way. For the FY11 cycle, the award is positioned as a driver for bold, field-shaping research rather than routine or incremental work.

What does the program mean by "innovative" research?

Innovation is defined broadly and can include introducing a new scientific paradigm, challenging widely held assumptions, reframing a long-standing problem from a different angle, or applying uniquely creative approaches. Innovation may also be reflected in the study concept, tools or technologies used, concepts for clinical interventions (as concepts rather than trials), or adapting existing methods and technologies to TSC in a genuinely new way.

Are incremental or stepwise extensions of prior work appropriate for this award?

No. Projects that primarily extend previously published findings in a stepwise or incremental manner are explicitly discouraged and may be considered non-responsive to the intent of the mechanism.

What kinds of research are encouraged under this opportunity?

Preclinical research is encouraged. This signals openness to laboratory studies, animal models, mechanistic experiments, biomarker development, and other translationally oriented efforts that do not involve human clinical trials.

Are clinical trials allowed under this award?

No. Clinical trials are not permitted under this award. Applicants need to shape any human-related work accordingly (for example, observational, mechanistic, or preparatory work rather than interventional clinical trials).

Can human-related research be included if it is not a clinical trial?

The announcement indicates that clinical trials are not permitted, but suggests that applicants may focus on non-trial human-related work such as observational, mechanistic, or preparatory studies, as long as it is not an interventional clinical trial.

Is preliminary data required?

Yes. Applicants are expected to include preliminary data that directly supports the feasibility and rationale of the proposed project. The program seeks creative ideas while still expecting credible early findings showing the work can be executed.

Is collaboration important for this award?

Yes. Collaboration is highlighted as a major priority. The FY11 TSCRP particularly encourages partnerships that strengthen translation from mechanism to patient relevance and accelerate movement from discovery to practical application.

What types of collaborations are specifically encouraged?

The opportunity encourages collaborations between basic scientists and clinical researchers, as well as collaborations between academic investigators and biotechnology or pharmaceutical industry scientists. Collaborations that bring in new disciplines or attract new investigators into TSC research are also strongly encouraged.

Who is the issuing agency for this funding opportunity?

This opportunity was issued by the Department of the Army (USAMRAA) under the Department of Defense.

What is the Funding Opportunity Number for this announcement?

The Funding Opportunity Number is W81XWH-11-TSCRP-IDA.

What is the funding instrument type?

The funding instrument type is listed as a cooperative agreement and grant.

What program category and CFDA number are associated with this opportunity?

The opportunity falls under the Science and Technology and other Research and Development category and is associated with CFDA 12.420, Military Medical Research and Development.

How many awards were anticipated, and what was the estimated total funding level?

The program anticipated making about three awards, with an estimated total funding level of $2.7 million.

Is cost sharing or matching required?

No. Cost sharing or matching is not required.

Who is eligible to apply?

Eligibility is described as unrestricted, meaning a wide range of entity types can apply, subject to any additional eligibility clarifications contained in the full announcement.

What were the key dates for the FY11 cycle?

The posting date was April 28, 2011. The original and final closing date was August 1, 2011. The archive date was August 31, 2011.

Is this opportunity still open?

Based on the provided dates, the FY11 cycle is archived (archive date: August 31, 2011) and had a final closing date of August 1, 2011.

Where can applicants get technical assistance for the announcement or submission systems?

For technical assistance with accessing the full announcement or submission systems, the notice directs applicants to CDMRP help resources (PA HELP and eReceipt HELP) via phone at 301-682-5507 or email at help@cdmrp.org.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DoD Neurofibromatosis Exploration Hypothesis Development Award

Previous opportunity: DoD Neurofibromatosis Investigator Initiated Research Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 11 TSCRP IDA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 11 TSCRP IDA) also looked into and applied for these:

Funding Opportunity
DoD Neurofibromatosis Exploration Hypothesis Development Award Apply for W81XWH 11 NFRP EHDA

Funding Number: W81XWH 11 NFRP EHDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Grant Program to Support State Judicial Outreach Liaisons (State JOLs) Apply for DTNH22 11 R 00480

Funding Number: DTNH22 11 R 00480
Agency: DOT/National Highway Traffic Safety Administration
Category: Science and Technology and other Research and Development
Funding Amount: $500,000
THE SILICON VALLEY EARTH SCIENCE COOPERATIVE AGREEMENT Apply for NNA11364917A

Funding Number: NNA11364917A
Agency: NASA Ames Research Center
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
ROSES 2011 Atmospheric Composition Laboratory Research Apply for NNH11ZDA001N ACLR

Funding Number: NNH11ZDA001N ACLR
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
ROSES 2011 Fellowships for Early Career Researchers Apply for NNH11ZDA001N ECF

Funding Number: NNH11ZDA001N ECF
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
ROSES 2011 Physical Oceanography Apply for NNH11ZDA001N PO

Funding Number: NNH11ZDA001N PO
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
ROSES 2011 IceSAT 2 Science Definition Team Apply for NNH11ZDA001N ICESAT2

Funding Number: NNH11ZDA001N ICESAT2
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Advanced Tactical Data Link (ATDL) Apply for ONRBAA11 021

Funding Number: ONRBAA11 021
Agency: Office of Naval Research
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Earth Sciences Instrumentation and Facilities Apply for 11 544

Funding Number: 11 544
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $14,000,000
Louis Stokes Alliances for Minority Participation Apply for 11 543

Funding Number: 11 543
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $5,000,000
DOD FY11 Tuberous Sclerosis Complex Clinical Trial Award Apply for W81XWH 11 TSCRP CTA

Funding Number: W81XWH 11 TSCRP CTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DOD FY11 Neurofibromatosis Clinical Trial Award Apply for W81XWH 11 NFRP CTA

Funding Number: W81XWH 11 NFRP CTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Joint Fire Science Program Apply for L11AS00082

Funding Number: L11AS00082
Agency: Bureau of Land Management
Category: Science and Technology and other Research and Development
Funding Amount: $633,518
Joint Fire Science Program Proposals Apply for L11AS00083

Funding Number: L11AS00083
Agency: Bureau of Land Management
Category: Science and Technology and other Research and Development
Funding Amount: $2,650,247
Prehospital Use of Plasma for Traumatic Hemorrhage Apply for W81XWH 11 PUPTH IIA

Funding Number: W81XWH 11 PUPTH IIA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: $8,000,000
Johnston Atoll Ant Eradication Technician Apply for 12510 1 J010

Funding Number: 12510 1 J010
Agency: Fish and Wildlife Service
Category: Science and Technology and other Research and Development
Funding Amount: $39,925
DoD Gulf War Illness Clinical Trial Development Award Apply for W81XWH 11 GWIRP CTDA

Funding Number: W81XWH 11 GWIRP CTDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Open Manufacturing Apply for DARPA BAA 11 54

Funding Number: DARPA BAA 11 54
Agency: DARPA Defense Sciences Office
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD FY11 Prostate Cancer Research Program Clinical Trial Award Apply for W81XWH 11 PCRP CTA

Funding Number: W81XWH 11 PCRP CTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD FY11 Prostate Cancer Research Program Impact Award Apply for W81XWH 11 PCRP IA

Funding Number: W81XWH 11 PCRP IA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 11 TSCRP IDA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.